Sumitomo Pharma Co. Ltd.

In News

Press Release Service: Sumitomo Pharma America Announces Enzomenib (DSP-5336) Receives FDA Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia - CRISPR Medicine News

CRISPR Medicine News - Jul 30, 2026

Sumitomo Pharma Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Revelio Labs - Jul 28, 2026

Sumitomo Pharma America Achieves Key Patient Enrollment Milestone for Pivotal Phase 2 Study of Enzomenib in the Treatment of Relapsed/Refractory Acute Leukemia - businesswire.com

businesswire.com - Jun 10, 2026

New Data from Sumitomo Pharma America at AUA 2026 Highlight Efficacy of Vibegron in Men Aged 75 and Older with Overactive Bladder and BPH - BioSpace

BioSpace - May 18, 2026

Short seller Gotham City Research accuses Sumitomo Pharma of misstating revenue - Investing.com

Investing.com - Aug 03, 2026

Sumitomo Pharma America Announces First Patient Receives Treatment in Phase 1/2a Study for its Investigational Therapy DSP-3077 for Retinitis Pigmentosa - Yahoo Finance

Yahoo Finance - Aug 12, 2026

Sumitomo Pharma America Announces Encouraging Clinical and Transl - The National Law Review

The National Law Review - Jul 15, 2026

Sumitomo Pharma Shares Drop After Stem-Therapy Backing - Bloomberg.com

Bloomberg.com - Feb 19, 2026

Cytonome Congratulates Sumitomo Pharma on Regulatory Approval for Regenerative Medicine Therapy for Parkinson’s disease - BioInformant

BioInformant - Mar 11, 2026

Knight Therapeutics Announces Regulatory Submission of GEMTESA® in Canada - The Manila Times

The Manila Times - Sep 15, 2026

Earnings call transcript: Sumitomo Pharma Q4 2025 sees record high net profit - Investing.com

Investing.com - May 21, 2026

Health panel approves coverage for iPS cell-derived Parkinson’s disease treatment - The Japan Times

The Japan Times - May 13, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment